Beckman Coulter’s earnings climb
- Share via
Medical diagnostic test maker Beckman Coulter Inc. posted a 56% jump in second-quarter earnings on demand for its genetic testing systems.
Net income increased to $69.4 million, or $1.09 a share, from $44.6 million, or 70 cents, a year earlier.
Quarterly revenue rose nearly 12% to $689.7 million.
Shares of Beckman Coulter gained 4 cents to $70.70.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
